FR2007515A1 - - Google Patents

Info

Publication number
FR2007515A1
FR2007515A1 FR6913027A FR6913027A FR2007515A1 FR 2007515 A1 FR2007515 A1 FR 2007515A1 FR 6913027 A FR6913027 A FR 6913027A FR 6913027 A FR6913027 A FR 6913027A FR 2007515 A1 FR2007515 A1 FR 2007515A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6913027A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2007515A1 publication Critical patent/FR2007515A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F24—HEATING; RANGES; VENTILATING
    • F24D—DOMESTIC- OR SPACE-HEATING SYSTEMS, e.g. CENTRAL HEATING SYSTEMS; DOMESTIC HOT-WATER SUPPLY SYSTEMS; ELEMENTS OR COMPONENTS THEREFOR
    • F24D19/00—Details

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Combustion & Propulsion (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thermal Sciences (AREA)
  • Cephalosporin Compounds (AREA)
FR6913027A 1968-04-25 1969-04-24 Withdrawn FR2007515A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72424668A 1968-04-25 1968-04-25

Publications (1)

Publication Number Publication Date
FR2007515A1 true FR2007515A1 (fr) 1970-01-09

Family

ID=24909645

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6913027A Withdrawn FR2007515A1 (fr) 1968-04-25 1969-04-24

Country Status (9)

Country Link
US (1) US3459749A (fr)
CH (1) CH521373A (fr)
DE (1) DE1921206A1 (fr)
DK (1) DK124757B (fr)
FR (1) FR2007515A1 (fr)
GB (1) GB1210489A (fr)
IE (1) IE33115B1 (fr)
IL (1) IL32035A (fr)
NL (1) NL160488C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2282269A1 (fr) * 1974-08-22 1976-03-19 Bayer Ag Nouveaux antibiotiques de la classe du b-lactame, leur procede de preparation et medicament les contenant

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1524026A (fr) * 1963-03-27 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et procédé pour leur préparation
FR1524027A (fr) * 1963-05-28 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et leur procédé de préparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3157648A (en) * 1961-08-25 1964-11-17 Smith Kline French Lab Derivatives of 7-aminocephalo-sporanic acid
US3382241A (en) * 1967-02-27 1968-05-07 Lilly Co Eli Certain orally active cephalosporin antibiotics

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1524026A (fr) * 1963-03-27 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et procédé pour leur préparation
FR1524027A (fr) * 1963-05-28 1968-05-10 Glaxo Lab Ltd Dérivés de l'acide 7-aminocéphalosporanique et leur procédé de préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2282269A1 (fr) * 1974-08-22 1976-03-19 Bayer Ag Nouveaux antibiotiques de la classe du b-lactame, leur procede de preparation et medicament les contenant

Also Published As

Publication number Publication date
DE1921206A1 (de) 1969-11-20
US3459749A (en) 1969-08-05
DK124757B (da) 1972-11-20
IL32035A0 (en) 1969-06-25
GB1210489A (en) 1970-10-28
NL160488B (nl) 1979-06-15
NL6906146A (fr) 1969-10-28
NL160488C (nl) 1979-11-15
IE33115L (en) 1969-10-25
CH521373A (de) 1972-04-15
IE33115B1 (en) 1974-03-20
IL32035A (en) 1972-07-26

Similar Documents

Publication Publication Date Title
AU5506869A (fr)
AU5184069A (fr)
AU6168869A (fr)
AU6171569A (fr)
AU2581067A (fr)
AU4811568A (fr)
FR2007515A1 (fr)
AU2580267A (fr)
AU4744468A (fr)
BE719042A (fr)
BE708933A (fr)
BE642636A (fr)
BE718283A (fr)
BE723759A (fr)
BE716127A (fr)
BE709496A (fr)
BE709484A (fr)
BE709479A (fr)
BE709446A (fr)
BE709435A (fr)
BE709415A (fr)
BE709320A (fr)
BE709319A (fr)
BE709301A (fr)
BE709274A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse